Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sonruvetcel
- Development stage
- Preclinical
- Lead developer
- Gallant
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Injection
01
Overview
Sonruvetcel is an investigational veterinary biologic therapy consisting of uterine-derived allogeneic mesenchymal stromal cells (UMSCs). Developed by the animal health biotechnology company Gallant, it is designed to treat refractory feline chronic gingivostomatitis (FCGS), a severe and painful inflammatory oral condition in cats. The therapy utilizes cells sourced from healthy, specific-pathogen-free, FDA-qualified feline donors, which are manufactured under current Good Manufacturing Practice (cGMP) conditions. Sonruvetcel represents a regenerative medicine approach, leveraging the immunomodulatory and anti-inflammatory properties of mesenchymal stromal cells to address the underlying pathology of FCGS. It is currently progressing through the FDA Center for Veterinary Medicine (CVM) approval process, with conditional approval targeted for early 2026.
- Other names
- uterine-derived allogeneic mesenchymal stromal cellsUMSCs
Beyond the preview
Go deeper on sonruvetcel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sonruvetcel.